PTC Therapeutics, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 3.25%311.290.0%$5240.07m
BNTXBioNTech SE 3.26%344.350.0%$1582.65m
NVAXNovavax, Inc. -0.65%160.9178.2%$851.92m
AMGNAmgen, Inc. 0.49%202.161.4%$596.16m
GILDGilead Sciences, Inc. -0.24%69.511.0%$508.61m
VRTXVertex Pharmaceuticals, Inc. -0.82%202.781.9%$475.09m
REGNRegeneron Pharmaceuticals, Inc. -1.10%627.032.7%$468.82m
LGVNLongeveron Inc. 17.89%21.220.0%$423.19m
ILMNIllumina, Inc. -3.12%346.333.3%$315.11m
SNSSSunesis Pharmaceuticals, Inc. -2.57%4.170.7%$291.50m
BIIBBiogen, Inc. -2.47%222.871.8%$272.09m
OCGNOcugen, Inc. -9.19%5.730.0%$192.28m
INCYIncyte Corp. -1.44%65.672.4%$153.98m
EXASEXACT Sciences Corp. -5.37%76.2518.0%$147.69m
SGENSeagen Inc. -4.92%150.865.8%$143.94m

Company Profile

PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of clinically differentiated medicines. It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The firm's portfolio includes Translarna, Emflaza, Tegsedi, Waylivra, and Evrysdi. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.